These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5324994)

  • 1. [Clinical evaluation of some butyrophenone derivatives].
    Bizoń E; Kakolewski J; Lewicka-Wysocka H
    Neurol Neurochir Psychiatr Pol; 1965; 15(6):889-92. PubMed ID: 5324994
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 3. A new butyrophenone derivative. AL-1021.
    Gallant DM; Bishop MP; Guerrero-Figueroa R; O'Meallie L
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):456-9. PubMed ID: 4979994
    [No Abstract]   [Full Text] [Related]  

  • 4. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
    Lehmann HE; Ban TA; Lee H
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
    Edwards JG; Simpson GM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
    [No Abstract]   [Full Text] [Related]  

  • 7. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 8. [Buronil (FG 5111)--a new butyrophenone derivative. A controlled clinical study on senile dementia and confusion].
    Simmelsgaard H; Mellergaard M; Vangtorp A
    Nord Med; 1967 Feb; 77(7):210-3. PubMed ID: 5336427
    [No Abstract]   [Full Text] [Related]  

  • 9. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
    Haugen T
    Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acute schizophrenia with a new butyrophenone-lenperone.
    Harris M
    J Clin Pharmacol; 1975; 15(2-3):187-90. PubMed ID: 1091666
    [No Abstract]   [Full Text] [Related]  

  • 11. [AHR-2277: a new major neuroleptic with minimal neurological side-effects].
    Denber HC
    Ann Med Psychol (Paris); 1973 Jan; 1(1):131-8. PubMed ID: 4723202
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
    Sathanathan GL; Angrist BM; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):844-7. PubMed ID: 4217252
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug therapy.
    Stone WN; Hofling CK; Winslow WW
    Prog Neurol Psychiatry; 1971; 26():529-51. PubMed ID: 4274994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary observations on the clinical use in psychiatry of a recent derivative of butyrophenone (Luvatrene)].
    Gori EC; Bonasegla F
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1304-14. PubMed ID: 5997230
    [No Abstract]   [Full Text] [Related]  

  • 15. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug therapy.
    Hofling CK; Winslow WW; Kellner R
    Prog Neurol Psychiatry; 1972; 27():339-54. PubMed ID: 4575598
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of trifluperidol in chronic schizophrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4916807
    [No Abstract]   [Full Text] [Related]  

  • 18. Lenperone: a controlled evaluation in chronic schizophrenic patients.
    Mielke DH; Gallant DM; Kessler C; Roniger JJ
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):636-40. PubMed ID: 812640
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia].
    Weiser G
    Wien Med Wochenschr; 1968 May; 118(19):444-6. PubMed ID: 5702494
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
    Gendron JL; Zimmermann RL; Schiele BC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.